Older adults experiencing irreversible blindness may now be able to see thanks to a system relying on a wireless retinal implant and high-tech glasses ...
According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...
The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...
About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...
DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, "Proteomics Tools Report: Research and Clinical markets (2025-2030).
Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...
A photovoltaic retinal implant shows promise as a way to improve vision in patients with advanced age-related macular ...
Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...
For more information on Bionano’s OGM solutions, visit www.bionano.com.
Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue growth and a raised full-year outlook. Investors are watching how recent ...
PRIMA system led to clinically meaningful improvement in visual acuity from baseline in 26 of 32 participants with 12 months of follow-up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback